Pharm of Anemia; Hematopoietic GFs Flashcards

(53 cards)

1
Q

Vitamin B12 deficiency

A

can lead to megaloblastic anemia, GI sxs, neuro abnorms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

chief dietary source of VitB12

A

meat, eggs, dairy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Common signs of anemia

A

Pallor, fatigue, dizziness, extertional dyspnea, other generalized sx of tissue hypoxia, & CV adaptations such as tachycardia, increased CO and vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Absence of adequate iron leads to what type of anemia?

A

Microcytic hypochromic anemia - small erythrocytes with insufficient hemoglobin are formed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Iron absorption

A

Duodenum & prox jejuni my

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When iron stores are high/iron requirements are low

A

Absorbed iron is diverted into ferritin in the intestinal epithelial mucosal cells for storage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Increased concentration of serum transferrin is associated with

A

Iron store depletion and iron deficiency anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Iron storage

A

As ferritin (complex of iron and apo-ferritin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

High levels of free iron stimulate production of apoferritin to reduce

A

Iron toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Oral iron therapy

A

Only ferrous salts should be used bc ferrous iron is most efficiently absorbed
-ferrous sulfate, ferrous gluconate, ferrous karate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ferrous salts adverse effects

A

Nausea, epigastric discomfort, abd cramps, constipation, black stools and diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Iron dextran

A

Par enteral iron therapy
-IV infusion -> can admin at higher dose
Adverse effects include: HA, light-headed mess, fever, athralgias, N/V, back pain, flushing, urticaria, bronchospasm, anaphylaxis and death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sodium ferry gluconate complex and iron-sucrose complex

A

Parenteral iron therapy
Only IV
Less likely to cause hypersensitivity rxns

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Acute iron toxicity

A

Young children who accidentally ingest iron tablets
-sx: necrotizing gastroenteritis, accompained by vomiting and abd pain and bloody diarrhea followed by shock, lethargy, dyspnea
-followed by severe metabolic acidosis, coma, death
Tx= parenteral deferoxamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Chronic iron toxicity

A

Excess iron deposits in heart, liver, pancreas, & other organs
-most common in pts with inherited hemochromatosis & pts who receive many red cell transfusions over a long period of time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Chronic iron toxicity tx

A

Intermittent phlebotomy

-oral iron chelator deferasirox reduces liver iron concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Vitamin B12 (Cobalamin) deficiency

A

Leads to Megaloblastic anemia (take 5 yrs to develop if absorption stopped completely), GI sx and neuro abnorms
-stored primarily in the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

B12 absorption

A

Absorbed after complexing with intrinsic factor (secreted by parietal cells); absorbed in distal ileum
-after absorption, B12 transported by transcobalamin I,II, III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

2 enzymatic rxns require B12

A

Synthesis of AA methionine & synthesis of succinyl-CoA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

B12 deficiency causes

A
  • Accumulation of N5-methylTHF and depletion of THF
  • accumulation of homocysteine -> incr serum levels
  • methylmalonic acid and methylmalonyl-CoA accumulate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Clinical manifestations of B12 deficiency

A

Megaloblastic, macrocytic anemia often with associated mild or mod leukopenia or thrombocytopenia and a characteristic hypercellular BM with an accumulation of Megaloblastic erythroid and other precursor cells
-neurologic syndrome associated with B12 def begins with paresthesias and peripheral nerves and weakness and progresses to spasticity, ataxia, & other CNS dysfxns

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Folic acid

A

Required for synthesis of AAs, purines and DNA

23
Q

Major consequence of folic acid deficiency

A

Anemia

-cause of congenital malformations in newborns and may play a role in vascular dz

24
Q

Richest sources of folic acid

A

Yeast, liver, kidney, green veggies

25
Unaltered Folic acid is absorbed
In the prox jejunum
26
Once inside cells, N5-methylTHF is converted to THF by the demethylation rxn that requires
VitB12
27
Folic acid deficiency results in
Megaloblastic anemia | -does not cause neurologic syndrome seen with B12 def
28
Drugs that cause folic acid deficiency
Methotrexate, trimethoprim, and pyrimethamine (all inhib DHFR)
29
Erythropoietin
Peritubular interstitial cells of the kidney | -binds to receptor on the surface of committed erythroid progenitors in the marrow after secretion
30
Inflammatory CKs suppresses
Erythropoietin secretion, iron delivery, and progenitor proliferation
31
RHuEPO, Epoetin alpha
IV admin | T 1/2 4-8 hrs but effects on marrow progenitors lasts much longer
32
Darbepoetin alpha
Modified form of erythropoietin that is more glycosylated and has a half life of 24-26 hrs
33
Erythropoietin pharmacodynamics
Induces erythropoiesis, induces release of reticulocytes from the BM into the bloodstream where they mature into erythrocytes -result in incr in reticulocytes counts (10 days) followed by a rise in hematocrit and Hb levels (2-6 wks)
34
Erythropoiesis-stimulating agents (ESAs)
Used in pts with anemia secondary to chronic kidney dz - always coupled with oral or parenteral iron supplementation (& sometimes folate) in pts with chronic kidney dz - may also be used for tx of anemia due to primary bone marrow disorders and secondary anemia so
35
Adverse effects of erythropoietin
HTN and thrombolytic complications
36
Myeloid GFs
Stimulate the proliferation and differentiation of one or more myeloid cells lines -enhance the fxn of mature granulocytes and monocytes
37
Filgrastim
Recombinant human G-CSF - nonglycosylated peptide - IV -> serum half life 2-3.5 hrs
38
Pegfilgrastim
Covalent conjugation product of Filgrastim and polyethylene glycol (PEG) Longer serum half life than Filgrastim
39
Sargramostim
Recombinant human GM-CSF
40
Plerixafor
Reversible inhibits binding of stromal cell-derived factor-1-alpha (SDF-1a) which is expressed on BM stromal cells, to the CXC chemokine receptor 4 (CXCR4) - results in mobilization of hematopoietic stem and progenitor cells from BM into PB - used in combo with Filgrastim results in synergistic incr in CD34+ cell mobilization prior to autologous transplantation - used in pts who respond sub optimally to G-CSF alone
41
G-CSF
Stimulates prolif and diff of progenitors already committed to the neutrophil lineage - activates the phagocytic activity of mature NTs and prolongs survival - Increases conc of HSCs in the PB
42
GM-CSF
Stimulate myelopoiesis -> prolif and diff of early and late granulocytic progenitor cells as well as erythroid and megakaryocytes progenitors - stimulates the fxn of mature NTs - stimulates T-cell proliferation together with IL-2
43
Cancer chemotherapy-induced neutropenia
G-CSF accelerates the rate of NT recovery after myelosuppressive chemo & reduce duration of neutropenia G-CSF reduces episodes of febrile neutropenia, Reqs for broad-spectrum antibiotics, infxs, & days of hospitalization
44
Pegfilgrastim vs Filgrastim
Pegfilgrastim may be admin less frequent and may shorten period of severe neutropenia
45
Filgrastim & Pegfilgrastim
Used more freq than GM-CSF -> better tolerated | Can cause bone pain
46
GM-CSF toxicity
Fever, malaise, athralgias, and a capillary leak syndrome characterized by peripheral edema and pleural or pericardial effusions
47
Megakaryocytes GFs
Pts with thrombocytopenia have a high risk of hemorrhage | Thrombopoietin and IL-11 are endogenous regulators of platelet production
48
IL-11: Oprelvekin
Recombinant form Activates specific cell surface CK receptors to stimulate the growth of multiple lymphoid and myeloid cells, stimulate the growth of primitive megakaryocytic progenitors; increases # of peripheral platelets and NTs
49
Romiplostim (recombinant thrombopoietin)
Activates Mpl thrombopoietin receptor to cause a dose-dependent increase in platelet count Increase in platelets begins 5 days after subQ injection, peaks 12-15 days
50
IL-11 is approved for
Secondary prevention of thrombocytopenia in pts receiving cytotoxic chemotherapy for no myeloid cancers
51
Romiplostim is approved for
Treatment of thrombocytopenia in pts with chronic immune (idiopathic) thrombocytopenia purpura (ITP)
52
IL-11 toxicity
Fatigue, headache, dizziness, CV effects (anemia, dyspnea, transient atrial arrhythmias - hypokalemia - all are reversible
53
Romiplostim toxicity
Well tolerated except for a mild HA on day of admin